GENENTA SCIENCE SPA
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
€0.72
+5.56%
Alpha Vantage · 11/10/2026
One-year price history
Adjusted daily closes · 252 observations · as of Nov 10, 2026
1 month
-5.5%
3 months
-44.8%
6 months
+17.1%
1 year
-67.4%
Year to date
-51.8%
52-week range
€0.58 – €2.22
Fundamental snapshot
Latest reported period: Dec 31, 2025
Market cap
€16.8M
P/E
-2.2
P/B
0.7
P/S
—
Revenue
€0
Net income
-€6.53M
Diluted EPS
-0.33
Gross margin
—
Net margin
—
Return on equity
-38.00%
Total debt
€7.6M
Cash
€5.53M
Free cash flow
-€6.88M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Dec 31, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
| Dec 31, 2023 | — | — | — | — | — |
| Jun 30, 2023 | — | — | — | — | — |
| Dec 31, 2022 | — | — | — | — | — |
| Jun 30, 2022 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent SAEN news
All market newsNo ticker-linked stories are in the current archive.